Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

C Palanca-Ballester, A Rodriguez-Casanova, S Torres… - Cancers, 2021 - mdpi.com
Simple Summary Apart from genetic changes, cancer is characterized by epigenetic
alterations, which indicate modifications in the DNA (such as DNA methylation) and histones …

DNA-methylation-based detection of urological cancer in urine: overview of biomarkers and considerations on biomarker design, source of DNA, and detection …

LK Larsen, GE Lind, P Guldberg, C Dahl - International journal of …, 2019 - mdpi.com
Changes in DNA methylation have been causally linked with cancer and provide promising
biomarkers for detection in biological fluids such as blood, urine, and saliva. The field has …

[HTML][HTML] VALHUDES: a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

M Arbyn, E Peeters, I Benoy, DV Broeck… - Journal of Clinical …, 2018 - Elsevier
Back ground Systematic reviews have concluded that hrHPV DNA testing using target-
amplification tests is as accurate on vaginal self-samples as on clinician-taken specimens …

Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel

V Constâncio, SP Nunes, C Moreira-Barbosa… - Clinical …, 2019 - Springer
Abstract Background Lung (LC), prostate (PCa) and colorectal (CRC) cancers are the most
incident in males worldwide. Despite recent advances, optimal population-based cancer …

Non-invasive detection of endometrial cancer by DNA methylation analysis in urine

R van den Helder, BMM Wever, NE van Trommel… - Clinical …, 2020 - Springer
Background The incidence of endometrial cancer is rising, and current diagnostics often
require invasive biopsy procedures. Urine may offer an alternative sample type, which is …

Detection of differentially methylated CpGs between tumour and adjacent benign cells in diagnostic prostate cancer samples

LM FitzGerald, C Jung, EM Wong, JHE Joo… - Scientific reports, 2024 - nature.com
Differentially methylated CpG sites (dmCpGs) that distinguish prostate tumour from adjacent
benign tissue could aid in the diagnosis and prognosis of prostate cancer. Previously, the …

Clinical biofluid assays for prostate cancer

T Borbiev, I Kohaar, G Petrovics - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) is the most frequent malignancy, and the second
leading cause of cancer-related death, in men in the United States. PCa detection has been …

[HTML][HTML] Epigenetic reprogramming during prostate cancer progression: a perspective from development

S Goel, V Bhatia, T Biswas, B Ateeq - Seminars in cancer biology, 2022 - Elsevier
Conrad Waddington's theory of epigenetic landscape epitomize the process of cell fate and
cellular decision-making during development. Wherein the epigenetic code maintains …

Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging

A Bakavicius, K Daniunaite, K Zukauskaite… - Clinical …, 2019 - Springer
Background Significant numbers of prostate cancer (PCa) patients experience tumour
upstaging and upgrading in surgical specimens that cause serious problems in timely and …

Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer

S Eickelschulte, AL Riediger, AK Angeles, F Janke… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer is a heterogeneous disease and a major cause of cancer
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …